Bio Techne Corp Stock Price To Earning
TE1 Stock | 71.50 0.50 0.69% |
Bio Techne Corp fundamentals help investors to digest information that contributes to Bio-Techne Corp's financial success or failures. It also enables traders to predict the movement of Bio-Techne Stock. The fundamental analysis module provides a way to measure Bio-Techne Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio-Techne Corp stock.
Bio-Techne |
Bio Techne Corp Company Price To Earning Analysis
Bio-Techne Corp's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition |
Based on the latest financial disclosure, Bio Techne Corp has a Price To Earning of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Price To Earning (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Bio-Techne Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio-Techne Corp's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio-Techne Corp could also be used in its relative valuation, which is a method of valuing Bio-Techne Corp by comparing valuation metrics of similar companies.Bio Techne is currently under evaluation in price to earning category among its peers.
Bio-Techne Fundamentals
Current Valuation | 13.06 B | |||
Price To Book | 7.56 X | |||
Price To Sales | 12.34 X | |||
Revenue | 1.11 B | |||
EBITDA | 413.76 M | |||
Net Income | 272.05 M | |||
Total Debt | 243.41 M | |||
Cash Flow From Operations | 325.27 M | |||
Price To Earnings To Growth | 1.11 X | |||
Market Capitalization | 16.22 B | |||
Total Asset | 2.29 B | |||
Z Score | 39.6 | |||
Annual Yield | 0.01 % | |||
Net Asset | 2.29 B |
About Bio-Techne Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio Techne Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio-Techne Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Techne Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bio-Techne Stock Analysis
When running Bio-Techne Corp's price analysis, check to measure Bio-Techne Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Techne Corp is operating at the current time. Most of Bio-Techne Corp's value examination focuses on studying past and present price action to predict the probability of Bio-Techne Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio-Techne Corp's price. Additionally, you may evaluate how the addition of Bio-Techne Corp to your portfolios can decrease your overall portfolio volatility.